Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder

J D Cance¹, E T Adams², E J D'Amico³, A Palimaru³, C S F Fernandes⁴, L E Fiellin⁴, E E Bonar^{5

6

7}, M A Walton^{5

6

7}, K A Komro⁸, D Knight⁹, K Knight⁹, V Rao¹⁰, S Youn¹⁰, L Saavedra², T A Ridenour², B Deeds¹¹

Affiliations

¹ RTI International, Research Triangle Park, Durham, NC, USA. jcance@rti.org.
² RTI International, Research Triangle Park, Durham, NC, USA.
³ RAND Corporation, Santa Monica, CA, USA.
⁴ Yale University School of Medicine, New Haven, CT, USA.
⁵ University of Michigan, Ann Arbor, MI, USA.
⁶ Injury Prevention Center, University of Michigan, Ann Arbor, MI, USA.
⁷ Addiction Center, University of Michigan, Ann Arbor, MI, USA.
⁸ Rollins School of Public Health, Emory University, Atlanta, USA.
⁹ Texas Christian University, Fort Worth, TX, USA.
¹⁰ Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
¹¹ National Institute on Drug Abuse, MD, Bethesda, USA.

PMID: 37261635
PMCID: PMC10689575
DOI: 10.1007/s11121-023-01545-x

Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder

J D Cance et al. Prev Sci. 2023 Oct.

. 2023 Oct;24(Suppl 1):30-39.

doi: 10.1007/s11121-023-01545-x. Epub 2023 Jun 1.

Authors

Affiliations

¹ RTI International, Research Triangle Park, Durham, NC, USA. jcance@rti.org.
² RTI International, Research Triangle Park, Durham, NC, USA.
³ RAND Corporation, Santa Monica, CA, USA.
⁴ Yale University School of Medicine, New Haven, CT, USA.
⁵ University of Michigan, Ann Arbor, MI, USA.
⁶ Injury Prevention Center, University of Michigan, Ann Arbor, MI, USA.
⁷ Addiction Center, University of Michigan, Ann Arbor, MI, USA.
⁸ Rollins School of Public Health, Emory University, Atlanta, USA.
⁹ Texas Christian University, Fort Worth, TX, USA.
¹⁰ Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
¹¹ National Institute on Drug Abuse, MD, Bethesda, USA.

PMID: 37261635
PMCID: PMC10689575
DOI: 10.1007/s11121-023-01545-x

Abstract

Substance use disorder prevention programs are most effective when matched appropriately to the baseline risk of the population. Individuals who misuse opioids often have unique risk profiles different from those who use other substances such as alcohol or cannabis. However, most substance use prevention programs are geared toward universal audiences, neglecting key inflection points along the continuum of care. The HEAL Prevention Cooperative (HPC) is a unique cohort of research projects that represents a continuum of care, from community-level universal prevention to indicated prevention among older adolescents and young adults who are currently misusing opioids or other substances. This paper describes the theoretical basis for addressing opioid misuse and opioid use disorder across the prevention continuum, using examples from research projects in the HPC.

Keywords: Behavioral health continuum of care; Evidence-based prevention programs; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Dr. Fiellin holds equity with Playbl, Inc., a small commercial venture that focuses on the distribution of evidence-based video games for risk reduction and prevention in youth and young adults. This relationship is extensively managed by Dr. Fiellin and her academic institution.

Figures

**Fig. 1**
The behavioral health continuum of care. Adapted from Institute of Medicine (1994). Reducing risks for mental disorders: Frontiers for preventive intervention research. The National Academies Press. https://doi.org/10.17226/2139

See this image and copyright information in PMC

Cited by

Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies.
Jalali A. Jalali A. Expert Rev Pharmacoecon Outcomes Res. 2024 Jun;24(5):599-611. doi: 10.1080/14737167.2024.2350561. Epub 2024 May 9. Expert Rev Pharmacoecon Outcomes Res. 2024. PMID: 38696161 Free PMC article. Review.
Understanding Opioid Use from Retrospective Accounts of Young Adults in Recovery: Motives, Experiences, and Implications for Prevention.
Ballard PJ, Vidrascu EM, Arnold TJ, Hernandez GC, Ozer EJ, Lassiter R, Nayyar H, Daniel SS, Wolfson M. Ballard PJ, et al. J Prev (2022). 2025 Jun 27. doi: 10.1007/s10935-025-00861-y. Online ahead of print. J Prev (2022). 2025. PMID: 40576917 No abstract available.
Commentary: Improving the Effectiveness and Utility of the Helping to End Addiction Long-Term (HEAL) Prevention Cooperative: A Full Translational Framework.
Andersen SL, Fishbein DH. Andersen SL, et al. Prev Sci. 2023 Oct;24(Suppl 1):111-118. doi: 10.1007/s11121-022-01477-y. Epub 2022 Dec 29. Prev Sci. 2023. PMID: 36580206 Free PMC article.
Prevalence and drug use correlates of inadvertent fentanyl exposure among individuals misusing drugs in seven U.S. states.
Magura S, Lee-Easton MJ, Abu-Obaid R, Reed P, Allgaier B, Fish E, Maletta AL, Amaratunga P, Lorenz-Lemberg B, Levitas M, Achtyes ED. Magura S, et al. J Addict Dis. 2024 Oct-Dec;42(4):515-523. doi: 10.1080/10550887.2023.2293643. Epub 2024 Feb 14. J Addict Dis. 2024. PMID: 38355422
Prevalence and Correlates of Alcohol and Drug Harms to Others: Findings From the 2020 U.S. National Alcohol Survey.
Rosen EM, Kerr WC, Patterson D, Greenfield TK, Ramos S, Karriker-Jaffe KJ. Rosen EM, et al. J Stud Alcohol Drugs. 2024 Nov;85(6):794-803. doi: 10.15288/jsad.23-00387. Epub 2024 Jun 2. J Stud Alcohol Drugs. 2024. PMID: 38830016

References

1. Acharya A, Izquierdo AM, Gonçalves SF, Bates RA, Taxman FS, Slawski MP, et al. (2022). Exploring county-level spatiotemporal patterns in opioid overdose related emergency department visits. PLoS ONE, 17(12):e0269509. 10.1371/journal.pone.0269509 - DOI - PMC - PubMed
1. Bao Y, Wen K, Johnson P, Jeng PJ, Meisel ZF, & Schackman BR (2018). Assessing the impact of state policies for prescription drug monitoring programs on high-risk opioid prescriptions. Health Affairs, 37(10), 1596–1604. 10.1377/hlthaff.2018.0512 - DOI - PMC - PubMed
1. Blanco C, Wall MM, & Olfson M (2022). Data needs and models for the opioid epidemic. Molecular Psychiatry, 27(2), 787–792. 10.1038/s41380-021-01356-y - DOI - PMC - PubMed
1. Blow FC, Barry KL, Walton MA, Maio RF, Chermack ST, Bingham CR, Ignacio RV, & Strecher VJ (2006). The efficacy of two brief intervention strategies among injured, at-risk drinkers in the emergency department: impact of tailored messaging and brief advice. Journal of Studies on Alcohol, 67(4), 568–578. 10.15288/jsa.2006.67.568 - DOI - PubMed
1. Bohnert AS, Bonar EE, Cunningham R, Greenwald MK, Thomas L, Chermack S, Blow FC, & Walton M (2016). A pilot randomized clinical trial of an intervention to reduce overdose risk behaviors among emergency department patients at risk for prescription opioid overdose. Drug and Alcohol Dependence, 163, 40–47. 10.1016/j.drugalcdep.2016.03.018 - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder

Affiliations

Leveraging the Full Continuum of Care to Prevent Opioid Use Disorder

Authors

Affiliations

Abstract

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical